発泡性錠剤の世界市場 - 2024年～2031年

発泡性錠剤の世界市場は2023年に99億8,000万米ドルに達し、2031年には201億3,000万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは9.17%で成長する見込みです。

発泡性錠剤は、クエン酸と炭酸水素ナトリウムからなる発泡性顆粒を圧縮して製造されます。これらの錠剤を水に浸すと、酸と塩基の反応により二酸化炭素が発生し、液体中に気泡として現れます。この錠剤の急速な崩壊により、迅速な溶解と吸収が促進されます。

発泡性錠剤の市場シェアは、利便性、栄養補助食品需要の高まり、医薬品用途、成長する店頭販売市場など、多くの分野にわたってその魅力と拡大を高める複数の変数によって影響を受けています。特定の発泡性錠剤を過剰に摂取すると、治療効果どころか有害な影響をもたらす可能性があり、そのため市場の拡大が制約されます。業界は、様々な原動力のおかげで大幅な拡大を受けています。

高齢者の間で発泡性錠剤の普及率が上昇していることは重要な開発であり、これらの錠剤は利便性を提供し、移動に困難がある人や固形物を飲み込むことが困難な人の摂取を容易にするからです。青少年や子供向けの発泡性サプリメントの普及は、市場の幅を広げており、多くの年齢層にとって汎用性の高い選択肢となっています。消化に長時間を要する可能性のある従来の医薬品とは対照的に、発泡性の体重減少サプリメントは、より迅速な作用の開始を提供するため、体重管理の努力においてより迅速な成果を促進します。

ダイナミクス

促進要因1-栄養補助食品に対する需要の高まり

栄養補助食品に対する需要の高まりは、健康とウェルネスを向上させるための簡単で快適かつ効果的な方法を追求する顧客が増加しているため、発泡性錠剤市場を大幅に促進しています。発泡性錠剤は吸収が早く、消化を促進するため、健康志向の人々に好まれる選択肢となっています。

特にミレニアル世代や健康愛好家の間で、ビタミン、ミネラル、ハーブのサプリメントに対する需要が高まっているため、メーカーは発泡性製品の開発と提供の幅を広げています。さらに、発泡性製剤の魅力は、風味の向上や楽しい消費体験につながることが多く、ライフスタイルに無理なく溶け込む機能的なアイテムを求める消費者の傾向と一致するため、この分野の成長を後押ししています。

ビタミンCは、免疫強化の特性を持つ栄養ビタミンとして知られています。発泡性ビタミンC錠剤は、その好みの味と便利な服用方法により、消費者の間で人気を博しています。発泡性ビタミンC錠剤は、従来のビタミンC錠剤やカプセルよりも水に溶けやすく、口当たりの良い発泡性の飲料を作ることができるため、好まれています。マルチビタミンは、各種ビタミンとミネラルを含む栄養補助食品として認知されています。

発泡性マルチビタミン・タブレットは、便利で楽しい方法で毎日の栄養所要量を満たすための包括的なソリューションを提供します。Council for Responsible NutritionのAnnual Survey on Dietary Supplements（栄養補助食品に関する年次調査）によると、米国における栄養補助食品の利用率は過去最高を記録しました。この世論調査によると、米国では個人の76％が栄養補助食品を利用しており、前年の74％から増加しています。このデータは、全体的な健康とウェルネスを高めるための栄養補助食品への関心と信頼が高まっていることを示しています。これは、発泡性錠剤業界の拡大を後押しするものです。

促進要因2-患者のコンプライアンスと治療効率の向上

特に高齢者、小児、嚥下障害のある患者など、従来の錠剤を飲み込むのが困難な患者において、患者のコンプライアンスを高める発泡性錠剤の能力は重要な要素です。この新しい製剤は、薬剤をおいしく飲みやすい液体に変えるもので、ヘルスケアにおける重要なアンメット・ニーズを満たすものです。

発泡技術には、単純な投与だけでなく様々な利点があります。発泡性錠剤は、有効医薬品成分（API）を大量に添加することで溶解性と生物学的利用能を高め、その結果、胃腸への刺激を抑えながら治療効果を促進します。水性環境下での酸塩基反応による速やかな溶解プロセスは、薬剤投与における有効性を示しています。この特性により、発泡性錠剤は疎水性であったり、特定のpH条件下で不安定であったりする医薬品有効成分に特に適しており、多様な治療領域でその有用性が拡大しています。

最近の技術革新は、発泡性錠剤の適応性を高めています。胃内滞留性製剤や徐放性製剤などの革新的な製剤は、標的薬物の分布を容易にし、消化管内での滞留時間を延長し、投与回数を最小限に抑えます。これにより治療効果が向上するだけでなく、副作用も軽減されるため、患者のコンプライアンスも向上します。

阻害要因：高い製造コスト

精巧な製造技術と特殊な包装が要求されるため、発泡性錠剤の製造コストは高いです。これらの錠剤は湿気に非常に弱いため、安定性を確保するためには湿度の低い調整された製造条件と密封包装が必要となります。高級な賦形剤と洗練された製剤を使用するため、製造コストが高くなります。FDAやEMAのような規制機関は、特に医薬品や栄養補助食品において、発泡性製品の安全性と有効性を保証するために厳格な品質基準を課しています。

製造業者は適正製造基準（GMP）を遵守し、これらの基準を満たすために厳しい試験を実施しなければならず、その結果、操業コストが上昇します。法外な経費は小売価格の上昇につながり、価格に敏感な市場での入手を制約します。この経済的障害は消費者の採用を制限し、特に新興地域における市場浸透を阻害するため、市場拡大の大きな制約となっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 栄養補助食品の需要増加
    • 患者のコンプライアンスと治療効率の向上
  • 抑制要因
    • 高い生産コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• DMIの見解

第6章 製品タイプ別

• 栄養補助食品
• 医薬品
• 栄養製品
• エネルギーブースター
• その他

第7章 形態別

• 腸溶錠
• 舌下錠
• チュアブルタブレット
• その他

第8章 パッケージングタイプ別

• プラスチック/アルミニウムチューブ
• サシェ
• ブリスター包装
• その他

第9章 タイプ別

• 処方箋
• 店頭

第10章 用途別

• パーソナルケアと美容
• 食品・飲料
• スポーツとフィットネス
• 海上
• その他

第11章 流通チャネル別

• 医薬品
• スーパーマーケット
• 電子商取引
• その他

第12章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第13章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第14章 企業プロファイル

• Pfizer Inc.
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Novartis AG
• Perrigo Company plc
• Bristol-Myers Squibb Company
• CHIESI SAS
• Hermes Pharma
• Herbalife International of America, Inc.
• Vovantis Laboratories
• Natur Produkt Zdrovit Sp Z O O
• Amerilab Technologies Inc.

第15章 付録

Global Effervescent Tablet Market reached US$ 9.98 billion in 2023 and is expected to reach US$ 20.13 billion by 2031, growing with a CAGR of 9.17% during the forecast period 2024-2031.

Effervescent tablets are manufactured by compressing effervescent granules composed of citric acid and sodium bicarbonate. When these tablets are immersed in water, the reaction between the acid and the base generates carbon dioxide, manifesting as gas bubbles in the liquid. The rapid disintegration of these tablets facilitates swift dissolving and absorption.

The market share of effervescent tablets is influenced by multiple variables that enhance their appeal and expansion across numerous sectors, including convenience, heightened demand for dietary supplements, pharmaceutical uses and the growing over-the-counter market. Excessive consumption of certain effervescent pills can lead to detrimental effects instead of therapeutic benefits, hence constraining market expansion. The industry is undergoing substantial expansion owing to various driving forces.

The rising prevalence of effervescent tablets among the elderly is a significant development, as these tablets provide convenience and facilitate intake for individuals with mobility challenges or difficulties in swallowing solid forms. The proliferation of effervescent supplements for youth and children is broadening the market's scope, rendering it a versatile option for many age demographics. In contrast to traditional drugs that may require extended digestion time, effervescent weight reduction supplements provide a more rapid commencement of action, hence promoting swifter outcomes in weight control endeavors.

Dynamics

Driver 1 - Growing Demand for Dietary Supplements

The rising demand for nutritional supplements is substantially propelling the effervescent tablet market as customers increasingly pursue easy, pleasant and efficacious methods to improve their health and wellness. Effervescent tablets provide rapid absorption and facilitate digestion, rendering them a favored option for health-conscious persons.

The increasing demand for vitamins, minerals and herbal supplements, especially among millennials and health aficionados, has prompted manufacturers to develop and broaden their effervescent product offerings. Moreover, the allure of effervescent formulations, frequently linked to enhanced flavor and pleasurable consumption experiences, corresponds with consumer inclinations for functional items that integrate effortlessly into their lifestyles, thereby propelling growth in this sector.

Vitamin C is a recognized dietary vitamin possessing immune-enhancing properties. Effervescent vitamin C tablets have gained popularity among customers due to their agreeable taste and convenient administration. Effervescent vitamin C tablets are favored over conventional vitamin C tablets or capsules due to their ability to dissolve in water, creating a palatable and effervescent beverage. Multivitamins are recognized nutritional supplements containing an assortment of vitamins and minerals.

Effervescent multivitamin tablets offer a comprehensive solution for fulfilling daily nutritional requirements in a convenient and enjoyable manner. The Council for Responsible Nutrition's Annual Survey on Dietary Supplements indicates that dietary supplement utilization in the US has reached a record peak. The poll indicates that 76% of individuals in the US will utilize dietary supplements, an increase from 74% the prior year. This data illustrates the increasing interest in and reliance on dietary supplements to enhance overall health and wellness. This propels the expansion of the effervescent tablet industry.

Driver 2 - Advancing Patient Compliance and Therapeutic Efficiency

The ability of effervescent tablets to enhance patient compliance, especially in patients who struggle to swallow traditional tablets, including the elderly, children and those with dysphagia, is a significant factor. This novel formulation converts medication into a tasty and easily ingestible fluid, fulfilling a significant unmet need in healthcare.

Effervescence technology has various advantages beyond simple administration. Effervescent tablets boost solubility and bioavailability by adding substantial quantities of Active Pharmaceutical Ingredients (APIs), resulting in expedited therapeutic effects with reduced gastrointestinal irritation. The fast dissolution process, driven by an acid-base reaction in an aqueous environment, illustrates their efficacy in drug administration. The characteristics render effervescent tablets especially appropriate for active pharmaceutical ingredients that are hydrophobic or unstable in certain pH conditions, thus expanding their utility across diverse therapeutic domains.

Recent innovations have enhanced the adaptability of effervescent pills. Innovations include gastro-retentive and slow-release formulations facilitate targeted medication distribution, extending residence duration in the gastrointestinal tract and minimizing dose frequency. This not only improves therapeutic results but also reduces adverse effects, hence increasing patient compliance.

Restraint: High Production Costs

The manufacturing of effervescent tablets is high due to the requirement for sophisticated production techniques and specific packaging. These pills are extremely susceptible to moisture, requiring regulated production conditions with low humidity and sealed packaging to ensure stability. The utilization of premium excipients and sophisticated formulations increases production expenses. Regulatory bodies like the FDA and EMA impose rigorous quality standards to guarantee the safety and efficacy of effervescent products, particularly in pharmaceutical and dietary supplement contexts.

Manufacturers must comply with Good Manufacturing Practices (GMP) and perform stringent testing to fulfill these standards, hence elevating operational costs. Exorbitant expenses can result in increased retail pricing, constraining accessibility in price-sensitive markets. This economic obstacle limits consumer adoption and impedes market penetration, especially in emerging areas, therefore serving as a substantial constraint on market expansion.

Segment Analysis

The global effervescent tablet market is segmented based on product type, form, packaging type, type, application, distribution channel and region.

Rising Enhanced Packaging

Aluminum and plastic tubes signify a notable improvement in packaging solutions for effervescent tablets, effectively mitigating essential issues related to moisture exposure that can negatively impact product quality. In the nutritional supplement sector, moisture can infiltrate packaging, resulting in early breakdown, color degradation, diminished efficacy or the emergence of unpleasant odors in effervescent pills.

In addition to moisture protection, the packaging design of aluminum and plastic tubes markedly improves brand visibility and consumer recognition at the point of sale. The potential for photorealistic printing enables firms to produce visually striking packaging that distinguishes itself in a saturated market.

Diverse surface textures, removable labels and cost-effective CMYK printing with a maximum of eight colors, inclusive of metallic finishes, empower businesses to convey vital product information in an appealing and clear manner. This focus on visual appeal, coupled with effective branding methods, corresponds with the growing consumer inclination towards health-oriented products, hence enhancing brand loyalty and consumer engagement.

The utilization of low-migration paints and varnishes that conform to international food safety standards highlights a dedication to safety and compliance in the packaging of effervescent tablets. By using for aluminium or plastic tubes for packaging, producers may safeguard their effervescent products from environmental influences while maintaining a professional and aesthetically pleasing presentation.

Geographical Penetration

Rising prevalence of chronic diseases in North America

The rising prevalence of chronic diseases and the presence of significant market players are ascribed to regional expansion. CDC statistics indicates that in 2020, there were 1,603,844 newly reported cancer cases in the US, along with 602,347 documented cancer-related deaths. For every 100,000 individuals, there were 403 newly diagnosed instances of cancer and 144 cancer-related fatalities. The FDA oversees dietary supplements and medications.

Dietary supplements, particularly effervescent tablets, are required to comply with FDA requirements. The FDA regulations safeguard product safety and quality, influencing market access and growth in North America. Moreover, the region's growing senior demographic and novel product launches propel market revenue.

Competitive Landscape

The major players in the market include Pfizer Inc., Novartis AG, Perrigo Company plc, Bristol-Myers Squibb Company, CHIESI SAS, Hermes Pharma, Herbalife International of America, Inc., Vovantis Laboratories, Natur Produkt Zdrovit Sp Z O O and Amerilab Technologies Inc.

Sustainability Analysis

The sustainability of the effervescent tablet market is supported by its environmentally friendly characteristics and its conformity with changing consumer and industry trends. Effervescent tablets, especially in cleaning applications, are biodegradable and eco-friendly, leaving no detrimental residues in ecosystems. Their compact, concentrated formulations diminish the necessity for unnecessary product application, therefore reducing waste and resource usage. This efficiency aligns with consumer aspirations for sustainable and economical cleaning solutions.

Innovations in packaging enhance the market's sustainability. Effervescent pills advantageously utilize the increasing transition towards bio-based and biodegradable packaging. Traditionally, the plastics sector depended significantly on fossil-derived materials; however, recent innovations have resulted in a greater utilization of renewable resources in packaging. Bio-based plastics, present in various forms since the 19th century, are seeing a resurgence, providing feasible solutions for mitigating the environmental impact of packaging.

Effervescent products also address the trend of minimizing packaging via e-commerce and subscription-based distribution models. These strategies correspond with consumer initiatives to reduce their ecological impact while maintaining convenience. The variety of effervescent tablets, which includes applications from denture cleaners to household cleaning agents, enhances their market appeal and emphasizes their contribution to sustainable consumption practices.

Consumer Behaviour Analysis

Consumer behavior regarding effervescent tablets indicates an increasing demand for alternative supplement delivery methods, as demonstrated by the surge in non-pill supplements, which currently represent approximately 34% of US supplement sales. The change is driven by consumers' inclination towards pleasurable and convenient alternatives, with formats like as candies, drink mixes and effervescent tablets becoming more favored than conventional pills. Gummy supplements have attained an impressive growth in recent years, underscoring the desire for formats that integrate functionality with an enjoyable experience.

Effervescent tablets provide a unique benefit by delivering nutrients in a palatable, carbonated beverage, attracting consumers who value flavor and convenience. These traits correspond with trends noted in other formats, where 52% of gummy consumers identify taste as the paramount characteristic, above affordability (37%) and high-quality components (25%). Effervescent pills address the demand for convenient, portable solutions that may be used without water, appealing to busy, health-conscious persons.

The increasing focus on clean-label supplements, propelled by Millennials and Gen Z, enhances the attractiveness of effervescent tablets. Consumers are progressively pursuing products containing natural ingredients, devoid of preservatives and artificial additives, hence affirming the appeal of effervescent tablets in the dynamic supplement industry.

Early Stage Innovations

Effervescent tablet formulations indicate an emerging invention with potential uses in sustained and gastro-retentive medication delivery systems. Recent developments underscore their promise in tackling critical obstacles including quick medication onset, restricted bioavailability and frequent dosage necessities. Effervescent tablets of nateglinide exhibited 99% drug release after 24 hours and maintained stability under diverse environmental conditions, addressing the limited duration of insulinotropic activity in the treatment of type II diabetes mellitus. The tablets, formulated using direct compression, employed excipients such as ethyl cellulose and Carbopol 930, with compatibility verified by FTIR and DSC analyses.

Effervescent floating tablets of fluoxetine for the treatment of depression demonstrated a 96% release within 12 hours, conforming to the Korsmeyer-Peppas release model. Their reliability is emphasized by stability under temperature and humidity fluctuations, as well as strong rheological qualities. Domperidone tablets exemplify a 98% release over 12 hours, underscoring their ability to improve medication absorption in particular gastrointestinal areas.

Effervescent formulations of silymarin flavonolignans for hepatic disorders demonstrated sustained release (95% over 16 hours), demonstrating zero-order kinetics and strong mechanical characteristics. These advances collectively highlight the potential of effervescent tablets to boost therapeutic results by improving drug delivery efficiency and patient compliance, indicating a disruptive approach in pharmaceutical research.

Emerging Market Players and Strategic Initiatives

Effervescent tablets are experiencing a renewed popularity because of changing customer preferences and innovations in manufacturing methods. Despite being generally regarded as an "old-fashioned" dosage type, their increasing market demand highlights its significance in contemporary healthcare. The global effervescent tablet market, valued at $356.3 million in 2023, is anticipated to expand at a strong CAGR of 6.8%, reaching $570.3 million by 2030. This expansion is propelled by their ease of consumption, better flavor and quick medicinal effects, which correspond with customer demands for convenience and an improved user experience.

New entrants are utilizing advanced manufacturing techniques, like TOPO granulation and unique horizontally aligned granulator technology, to enhance the stability, flavor and cost-effectiveness of effervescent tablets. These innovations facilitate accelerated production cycles, diminished carbon footprints and improved shelf life, especially in adverse climates.

Pharmaceutical companies are now strategically reintroducing effervescent tablets as luxury products, leveraging recent technology advancements. Companies are investigating novel formulations with distinctive active ingredients to address various customer categories, including the elderly and younger populations. In doing so, businesses are both broadening their product ranges and strengthening their market position in a competitive and dynamic environment.

Key Developments

• In April 2022, Health Innovations Ltd., a UK-based maker of healthcare supplements, launched a novel EfferShield technology for effervescent pills and powders. This proprietary method has been designed to offer clients easy packaging solutions, including single-use pouches and stick packs.

Why Purchase the Report?

• To visualize the global effervescent tablet market segmentation based on product type, form, packaging type, type, application, distribution channel and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the effervescent tablet market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global effervescent tablet market report would provide approximately 86 tables, 88 figures and 202 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Form
• 3.3. Snippet by Packaging Type
• 3.4. Snippet by Type
• 3.5. Snippet by Application
• 3.6. Snippet by Distribution Channel
• 3.7. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing Demand for Dietary Supplements
    • 4.1.1.2. Advancing Patient Compliance and Therapeutic Efficiency
  • 4.1.2. Restraints
    • 4.1.2.1. High Production Costs
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. DMI Opinion

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Nutritional Supplements*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Pharmaceuticals
• 6.4. Dietary Products
• 6.5. Energy Boosters
• 6.6. Others

7. By Form

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 7.1.2. Market Attractiveness Index, By Form
• 7.2. Enteric Coated Tablets*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Sublingual Tablets
• 7.4. Chewable Tablets
• 7.5. Others

8. By Packaging Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 8.1.2. Market Attractiveness Index, By Age Group
• 8.2. Plastic/Aluminium Tubes*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Sachets
• 8.4. Blister Packaging
• 8.5. Others

9. By Type

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.1.2. Market Attractiveness Index, By Type
• 9.2. Prescription*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Over the counter

10. By Application

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.1.2. Market Attractiveness Index, By Application
• 10.2. Personal Care and Beauty*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Food and Beverage
• 10.4. Sports and Fitness
• 10.5. Marine
• 10.6. Others

11. By Distribution Channel

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.1.2. Market Attractiveness Index, By Distribution Channel
• 11.2. Pharmaceuticals*
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 11.3. Supermarkets
• 11.4. eCommerce
• 11.5. Others

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.2.9.1. US
    • 12.2.9.2. Canada
    • 12.2.9.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.3.9.1. Germany
    • 12.3.9.2. UK
    • 12.3.9.3. France
    • 12.3.9.4. Italy
    • 12.3.9.5. Spain
    • 12.3.9.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.4.9.1. Brazil
    • 12.4.9.2. Argentina
    • 12.4.9.3. Rest of South America
• 12.5. Asia Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.5.9.1. China
    • 12.5.9.2. India
    • 12.5.9.3. Japan
    • 12.5.9.4. Australia
    • 12.5.9.5. Rest of Asia Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
  • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Competitive Landscape

• 13.1. Competitive Scenario
• 13.2. Market Positioning/Share Analysis
• 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

• 14.1. Pfizer Inc.*
  • 14.1.1. Company Overview
  • 14.1.2. Product Portfolio and Description
  • 14.1.3. Financial Overview
  • 14.1.4. Key Developments
• 14.2. Novartis AG
• 14.3. Perrigo Company plc
• 14.4. Bristol-Myers Squibb Company
• 14.5. CHIESI SAS
• 14.6. Hermes Pharma
• 14.7. Herbalife International of America, Inc.
• 14.8. Vovantis Laboratories
• 14.9. Natur Produkt Zdrovit Sp Z O O
• 14.10. Amerilab Technologies Inc.

LIST NOT EXHAUSTIVE

15. Appendix

• 15.1. About Us and Services
• 15.2. Contact Us